Traumatic Brain Injury (TBI) Management Analysis

This question concerns the initial management of a pediatric patient with severe traumatic brain injury (TBI) presenting with signs of significantly elevated intracranial pressure (ICP).

Patient Presentation and Key Findings

• Age: 10-year-old girl
• Condition: Severe TBI following a road traffic accident
• Neurological Status: Comatose, Glasgow Coma Scale (GCS) score of 4
• Vital Signs: Hypertensive, bradycardia (suggesting Cushing's triad)
• Physical Exam: Extensor posturing (decerebrate or decorticate rigidity)
• CT Imaging: Comminuted skull fractures and intraparenchymal hemorrhage

These findings collectively indicate a critical intracranial event with likely sustained brain injury and markedly increased ICP.

Goals of Initial TBI Management

The primary goals are to prevent secondary brain injury by:

• Maintaining adequate cerebral oxygenation and perfusion.
• Reducing elevated intracranial pressure (ICP).
• Managing intracranial lesions.

Evaluating Management Options

The question asks to identify the measure NOT indicated in the initial management of this severe TBI case:

• 1. Head of bed elevation: Elevating the head of the bed to 30 degrees is a standard intervention to facilitate cerebral venous drainage and reduce ICP. This is indicated.
• 2. Mechanical ventilation: Ensuring adequate ventilation and oxygenation is crucial. In severe TBI with elevated ICP, controlled hyperventilation (targeting $P_{a}CO_2$ between 30-35 mmHg) may be used judiciously as a temporizing measure to rapidly decrease ICP. This is indicated.
• 3. Intravenous dexamethasone: Corticosteroids like dexamethasone are effective for reducing vasogenic edema associated with brain tumors or abscesses. However, large clinical trials (e.g., CRASH trial) have shown that corticosteroids **do not** improve outcomes and may even increase mortality in patients with TBI. They are **contraindicated** in the acute phase of TBI.
• 4. Hypertonic saline administration: Hypertonic saline solutions (e.g., 3% NaCl) are osmotherapeutic agents used to decrease ICP by drawing water out of the brain tissue. They are a key component of managing elevated ICP in TBI. This is indicated.

Conclusion

Based on current evidence-based guidelines for traumatic brain injury management, intravenous dexamethasone is the intervention that should be excluded. The patient's presentation requires measures focused on ICP reduction and hemodynamic stability, none of which include corticosteroids.

Therefore, the management measure that should be EXCLUDED is Intravenous dexamethasone.